http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108658952-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
filingDate 2017-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2020-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108658952-B
titleOfInvention Preparation method of vilazodone hydrochloride IV crystal
abstract The invention relates to the field of pharmaceutical chemistry, and provides a novel preparation method of vilazodone IV-type crystals. A method for preparing vilazodone hydrochloride IV type crystals is characterized by adding a vilazodone crude product and sodium metabisulfite into a crystallization solvent, heating until the vilazodone crude product and the sodium metabisulfite are dissolved, adding isopropanol hydrochloride, stirring for 0-24 hours at the same temperature under heat preservation, slowly cooling to a certain temperature for crystallization for 0-24 hours, carrying out suction filtration, washing a filter cake by using an organic solvent, and drying to obtain vilazodone IV type crystals. Compared with the existing preparation method of vilazodone IV crystal, the preparation method has simpler operation and obtains the vilazodone IV crystal with high purity in high yield.
priorityDate 2017-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015037010-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918314
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21912024
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525513
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12564590
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426248706
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421888096
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456987945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448616730
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425413332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452450343
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21885828
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID656671
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665763
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419480019
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8108
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449472542
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448478793
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21941165
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447586071
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7519
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918313

Total number of triples: 40.